Eur Rev Med Pharmacol Sci 2020; 24 (8): 4597-4606

DOI: 10.26355/eurrev_202004_21046

An update on the status of COVID-19: a comprehensive review

N. Zhao, Z.-L. Zhou, L. Wu, X.-D. Zhang, S.-B. Han, H.-J. Bao, Y. Shu, X.-G. Shu

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. shuxiaogang_whuh@163.com


The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).

Free PDF Download

To cite this article

N. Zhao, Z.-L. Zhou, L. Wu, X.-D. Zhang, S.-B. Han, H.-J. Bao, Y. Shu, X.-G. Shu
An update on the status of COVID-19: a comprehensive review

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 8
Pages: 4597-4606
DOI: 10.26355/eurrev_202004_21046